Skip to main content
Healthcare

Why pharma firms are betting billions on psychedelic drugs despite setbacks

Why pharma firms are betting billions on psychedelic drugs despite setbacks

Feed excerpt — reported by Nature

Nature, Published online: 27 October 2026; doi:10.1038/d41586-026-03390-8Regulatory pushback stalled the field. But researchers are optimistic about mind-altering drugs as potential treatments for depression and mood disorders.

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at Nature →

Original Source

This article was syndicated from Nature. All rights remain with the original publisher.